Literature DB >> 11571931

Acromegaly.

A Ben-Shlomo1, S Melmed.   

Abstract

Acromegaly is a slow developing disease caused by hypersecretion of growth hormone and insulin-like growth factor 1. Increased morbidity and mortality associated with the disease make early diagnosis and treatment crucial. This article reviews the etiology, clinical manifestations, and diagnosis of acromegaly, with an emphasis on newly available therapeutic options.

Entities:  

Mesh:

Year:  2001        PMID: 11571931     DOI: 10.1016/s0889-8529(05)70202-4

Source DB:  PubMed          Journal:  Endocrinol Metab Clin North Am        ISSN: 0889-8529            Impact factor:   4.741


  7 in total

Review 1.  Musculoskeletal complications of acromegaly: what radiologists should know about early manifestations.

Authors:  A Tagliafico; E Resmini; D Ferone; C Martinoli
Journal:  Radiol Med       Date:  2011-03-19       Impact factor: 3.469

Review 2.  Medical management of pituitary adenomas: the special case of management of the pregnant woman.

Authors:  Marcello Delano Bronstein; Luiz Roberto Salgado; Nina Rosa de Castro Musolino
Journal:  Pituitary       Date:  2002       Impact factor: 4.107

3.  Rheumatoid arthritis masquerading as acromegaly recurrence: report of two cases.

Authors:  Yusuf Aydın; Hülya Coşkun; Seher Kır; Selma Yazici; Özlem Kudaş; Adem Güngör
Journal:  Rheumatol Int       Date:  2010-04-06       Impact factor: 2.631

4.  Gingival enlargement in acromegaly.

Authors:  I Capoglu; A B Yilmaz; N Unüvar; R Orbak; H Aksoy; H Yesilyurt
Journal:  Endocrine       Date:  2002-08       Impact factor: 3.633

5.  Is every joint symptom related to acromegaly?

Authors:  Gonca Örük; Figen Tarhan; Mehmet Argın; Mustafa Özmen
Journal:  Endocrine       Date:  2012-08-21       Impact factor: 3.633

Review 6.  Octreotide long-acting release (LAR): a review of its use in the management of acromegaly.

Authors:  Kate McKeage; Susan Cheer; Antona J Wagstaff
Journal:  Drugs       Date:  2003       Impact factor: 9.546

Review 7.  Pathogenesis and prevalence of hypertension in acromegaly.

Authors:  M Bondanelli; M R Ambrosio; E C degli Uberti
Journal:  Pituitary       Date:  2001-09       Impact factor: 4.107

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.